Ashish Kamat is a Urologist in Houston, Texas. Dr. Kamat is rated as an Elite provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Lymphadenectomy.

Seth P. Lerner, MD, is Professor of Urology and holds the Beth and Dave Swalm Chair in Urologic Oncology, in the Scott Department of Urology, Baylor College of Medicine. He is Director of Urologic Oncology and the Multidisciplinary Bladder Cancer Program and Faculty Group Practice Medical Director for the Urology Clinic. He earned his medical degree from Baylor College of Medicine, completed a surgical internship at Virginia Mason Hospital in Seattle, and returned to Baylor for his residency training. He completed a two-year fellowship at the University of Southern California in urologic oncology and reconstructive surgery under Peter Jones and Don Skinner before returning to join the full-time Baylor faculty in 1992. His clinical practice, education, and research activities are devoted to urologic oncology and particularly lower and upper tract urothelial cancer. Dr. Lerner is author of more than 160 peer-reviewed articles, and co-editor of a comprehensive Textbook of Bladder Cancer. Dr. Lerner is an active member of the prestigious American Association of Genitourinary surgeons and is listed routinely among America's Top Doctors and Best Doctors in America. He established and directs the multi-disciplinary Bladder Cancer Research Program at Baylor, and his research interests include use of selective estrogen receptor modulators for treatment of bladder cancer, gene therapy, targeted molecular therapeutics, and outcomes of radical cystectomy and pelvic lymphadenectomy. He has 22 years of experience as a clinical investigator for both NCI and industry funded clinical trials. He is the PI of the ongoing SWOG NCI Phase III trial comparing extended vs. standard pelvic lymphadenectomy at time of radical cystectomy for muscle invasive bladder cancer. He is active in the leadership of several national bladder cancer research enterprises including chair of the Local Bladder Cancer committee of SWOG, co-chair of the NCI's Bladder Cancer Task Force and the Analysis Working Group of The Cancer Genome Atlas Project for muscle invasive bladder cancer. He is very active in the Bladder Cancer Advocacy Network (BCAN) as a member of the Board of Directors, past chair of the Bladder Cancer Think Tank and co-chair of the management committee of the Bladder Cancer Research Network. Dr. Lerner is rated as an Elite provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Lymphadenectomy.

Peter Black is a Urologist in Houston, Texas. Dr. Black is rated as an Elite provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy.

Omar Alhalabi is a Hematologist Oncology specialist and a Hematologist in Houston, Texas. Dr. Alhalabi is rated as an Elite provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Urothelial Cancer, Renal Cell Carcinoma (RCC), Bladder Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Nephrectomy.

Arlene Siefker-Radtke is an Oncologist in Houston, Texas. Dr. Siefker-Radtke is rated as an Elite provider by MediFind in the treatment of Urothelial Cancer. Her top areas of expertise are Urothelial Cancer, Bladder Cancer, Urachal Cancer, Nephrectomy, and Lymphadenectomy.

Surena Matin is a Urologist in Houston, Texas. Dr. Matin is rated as an Elite provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Reconstructive Urology Surgery.

Colin Dinney is a Urologist in Houston, Texas. Dr. Dinney has been practicing medicine for over 44 years and is rated as an Elite provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Lymphadenectomy.

Neema Navai is a Urologist in Houston, Texas. Dr. Navai is rated as an Elite provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Prostatectomy.

Lisly Chery is a Urologist in Houston, Texas. Dr. Chery has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Prostate Cancer, Malakoplakia, Familial Prostate Cancer, Nephrectomy, and Prostatectomy.

Anil Sood is a Gynecologic Oncologist and an Oncologist in Houston, Texas. Dr. Sood is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Sertoli-Leydig Cell Tumor, Endoscopy, and Oophorectomy.

Brian Chapin is a Urologist in Houston, Texas. Dr. Chapin is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy.

John Heymach is an Oncologist in Houston, Texas. Dr. Heymach is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Tissue Biopsy.

Jenny Pozadzides is a Hematologist and an Oncologist in Houston, Texas. Dr. Pozadzides is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. Her top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Neuroendocrine Tumor.

Jianjun Zhang is an Oncologist in Houston, Texas. Dr. Zhang is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), Hepatectomy, and Endoscopy.

Anne Tsao is an Oncologist and a Hematologist in Houston, Texas. Dr. Tsao is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. Her top areas of expertise are Mesothelioma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Thymic Epithelial Tumor, and Tissue Biopsy.

Raj Satkunasivam is a Urologist in Houston, Texas. Dr. Satkunasivam is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Bladder Cancer, Renal Cell Carcinoma (RCC), Urothelial Cancer, Cystectomy, and Nephrectomy. Dr. Satkunasivam is currently accepting new patients.

Jose Karam is a Urologist in Houston, Texas. Dr. Karam is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Upper Tract Urothelial Carcinoma (UTUC), Nephrectomy, and Thrombectomy.

Jianjun Gao is an Oncologist in Houston, Texas. Dr. Gao is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Urothelial Cancer, Bladder Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Nephrectomy.

John Papadopoulos is a Urologist in Houston, Texas. Dr. Papadopoulos is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Urothelial Cancer, Prostate Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Papadopoulos is currently accepting new patients.

Matthew Campbell is a Hematologist and an Oncologist in Houston, Texas. Dr. Campbell is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, and Nephrectomy.